103 related articles for article (PubMed ID: 22045456)
1. In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.
Müller JM; Wissemann J; Meli ML; Dasen G; Lutz H; Heinzerling L; Feige K
Schweiz Arch Tierheilkd; 2011 Nov; 153(11):509-13. PubMed ID: 22045456
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses.
Müller J; Feige K; Wunderlin P; Hödl A; Meli ML; Seltenhammer M; Grest P; Nicolson L; Schelling C; Heinzerling LM
J Immunother; 2011 Jan; 34(1):58-64. PubMed ID: 21150713
[TBL] [Abstract][Full Text] [Related]
3. Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent.
Schnabel CL; Steinig P; Koy M; Schuberth HJ; Juhls C; Oswald D; Wittig B; Willenbrock S; Murua Escobar H; Pfarrer C; Wagner B; Jaehnig P; Moritz A; Feige K; Cavalleri JM
BMC Vet Res; 2015 Jun; 11():140. PubMed ID: 26100265
[TBL] [Abstract][Full Text] [Related]
4. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Heinzerling L; Burg G; Dummer R; Maier T; Oberholzer PA; Schultz J; Elzaouk L; Pavlovic J; Moelling K
Hum Gene Ther; 2005 Jan; 16(1):35-48. PubMed ID: 15703487
[TBL] [Abstract][Full Text] [Related]
6. Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.
Mählmann K; Feige K; Juhls C; Endmann A; Schuberth HJ; Oswald D; Hellige M; Doherr M; Cavalleri JM
BMC Vet Res; 2015 May; 11():107. PubMed ID: 25967290
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.
Mählmann K; Feige K; Juhls C; Endmann A; Schuberth HJ; Oswald D; Hellige M; Doherr M; Cavalleri JM
BMC Vet Res; 2015 Jun; 11():132. PubMed ID: 26063232
[TBL] [Abstract][Full Text] [Related]
8. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
[TBL] [Abstract][Full Text] [Related]
10. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
11. Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study.
Imboden M; Shi F; Pugh TD; Freud AG; Thom NJ; Hank JA; Hao Z; Staelin ST; Sondel PM; Mahvi DM
Hum Gene Ther; 2003 Jul; 14(11):1037-48. PubMed ID: 12885344
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
[TBL] [Abstract][Full Text] [Related]
13. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
14. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses.
Heinzerling LM; Feige K; Rieder S; Akens MK; Dummer R; Stranzinger G; Moelling K
J Mol Med (Berl); 2001; 78(12):692-702. PubMed ID: 11434722
[TBL] [Abstract][Full Text] [Related]
15. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
Wattrang E; Berg M; Magnusson M
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis.
Horohov DW; Breathnach CC; Sturgill TL; Rashid C; Stiltner JL; Strong D; Nieman N; Holland RE
Equine Vet J; 2008 Jul; 40(5):468-72. PubMed ID: 18678554
[TBL] [Abstract][Full Text] [Related]
18. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation.
Heller R; Schultz J; Lucas ML; Jaroszeski MJ; Heller LC; Gilbert RA; Moelling K; Nicolau C
DNA Cell Biol; 2001 Jan; 20(1):21-6. PubMed ID: 11242540
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced increases in inflammatory cytokines in muscle and blood of horses.
Liburt NR; Adams AA; Betancourt A; Horohov DW; McKeever KH
Equine Vet J Suppl; 2010 Nov; (38):280-8. PubMed ID: 21059019
[TBL] [Abstract][Full Text] [Related]
20. Constant and steady transgene expression of interferon-γ by optimization of plasmid construct for safe and effective interferon-γ gene therapy.
Ando M; Takahashi Y; Nishikawa M; Watanabe Y; Takakura Y
J Gene Med; 2012 Apr; 14(4):288-95. PubMed ID: 22359360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
